Literature DB >> 19249298

Antidepressant-like effects of melatonin in the mouse chronic mild stress model.

Bernardo C Detanico1, Angelo L Piato, Jennifer J Freitas, Francisco L Lhullier, Maria P Hidalgo, Wolney Caumo, Elaine Elisabetsky.   

Abstract

Melatonin is a hormone primarily synthesized by the pineal gland and has been shown to govern seasonal and circadian rhythms, as well as the immune system, certain behaviours, and responses to stress. Chronic exposure to stress is involved in the etiology of human depression, and depressed patients present changes in circadian and seasonal rhythms. This study investigated the effects of daily exogenous melatonin (1 and 10 mg/kg, p.o.) and imipramine (20 mg/kg, i.p.) on the changes in the coat state, grooming behaviour and corticosterone levels induced by the unpredictable chronic mild stress model of depression in mice. As expected, the 5 weeks of unpredictable chronic mild stress schedule induced significant degradation of the coat state, decreased grooming and increased serum corticosterone levels. All of these unpredictable chronic mild stress-induced changes were counteracted by melatonin (P<0.05) and imipramine (P<0.01). Especially in view of the relevance of stress as a major contributing factor in depression, as well as the alleged importance of normalizing a hyperfunctioning HPA axis and resynchronizing circadian rhythms for a successful treatment of depression, this study reassesses the potential of melatonin as an antidepressant.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19249298     DOI: 10.1016/j.ejphar.2009.02.037

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  28 in total

Review 1.  Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies.

Authors:  Jennifer M Loftis; Marilyn Huckans; Benjamin J Morasco
Journal:  Neurobiol Dis       Date:  2009-11-26       Impact factor: 5.996

Review 2.  Circadian modulation of neuroplasticity by melatonin: a target in the treatment of depression.

Authors:  Marcela Valdés-Tovar; Rosa Estrada-Reyes; Héctor Solís-Chagoyán; Jesús Argueta; Ana María Dorantes-Barrón; Daniel Quero-Chávez; Ricardo Cruz-Garduño; Montserrat G Cercós; Citlali Trueta; Julián Oikawa-Sala; Margarita L Dubocovich; Gloria Benítez-King
Journal:  Br J Pharmacol       Date:  2018-04-17       Impact factor: 8.739

3.  The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice.

Authors:  Or Burstein; Ravid Doron
Journal:  J Vis Exp       Date:  2018-10-24       Impact factor: 1.355

4.  The effects of fluoxetine treatment in a chronic mild stress rat model on depression-related behavior, brain neurotrophins and ERK expression.

Authors:  Maya First; Irit Gil-Ad; Michal Taler; Igor Tarasenko; Nurit Novak; Abraham Weizman
Journal:  J Mol Neurosci       Date:  2011-04-09       Impact factor: 3.444

5.  A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation.

Authors:  Michele Fornaro; Davide Prestia; Salvatore Colicchio; Giulio Perugi
Journal:  Curr Neuropharmacol       Date:  2010-09       Impact factor: 7.363

6.  Therapeutic application of melatonin in mild cognitive impairment.

Authors:  Daniel P Cardinali; Daniel E Vigo; Natividad Olivar; María F Vidal; Analía M Furio; Luis I Brusco
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

7.  Antidepressant-like effects and memory enhancement of a herbal formula in mice exposed to chronic mild stress.

Authors:  Xiu-Ping Sun; Si-Di Li; Zhe Shi; Teng-Fei Li; Rui-Le Pan; Qi Chang; Chuan Qin; Xin-Min Liu
Journal:  Neurosci Bull       Date:  2013-10-16       Impact factor: 5.203

8.  Melatonin potentiates running wheel-induced neurogenesis in the dentate gyrus of adult C3H/HeN mice hippocampus.

Authors:  Jiabei Liu; Kathleen C Somera-Molina; Randall L Hudson; Margarita L Dubocovich
Journal:  J Pineal Res       Date:  2012-11-28       Impact factor: 13.007

Review 9.  Melatonin for cognitive impairment.

Authors:  S L Jansen; D A Forbes; V Duncan; D G Morgan
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

10.  Neuroimmune endocrine effects of antidepressants.

Authors:  Marco Antonioli; Joanna Rybka; Livia A Carvalho
Journal:  Neuropsychiatr Dis Treat       Date:  2012-02-07       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.